相关实验视频
Updated: May 28, 2025

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
369
ZCCHC4通过ROS/c-myc轴调节食道癌的进展和对西斯普拉丁的耐药性
Lihua Yao1,2, Piao Wu1, Fangyi Yao2
1Department of Clinical Laboratory, Affiliated Hospital of North Sichuan Medical College, School of Clinical Medicine, North Sichuan Medical College, Nanchong, 637000, Sichuan, China.
Scientific reports
|February 11, 2025
概括
低调指CCHC类型含有4 (ZCCHC4) 增强食道癌细胞对西斯普拉丁的敏感性,抑制增殖,并通过ROS/c-myc轴促进细胞亡. 这表明ZCCHC4是食道癌的潜在诊断和治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 指CCHC类型含有4 (ZCCHC4) 是一种N6-甲基氨酸RNA甲基转移酶,涉及各种癌症.
- 它在食道癌 (ESCA) 中的作用仍然在很大程度上未被描述.
- 异常ZCCHC4表达与其他恶性瘤的不良预后和化学抵抗有关.
研究的目的:
- 研究食道癌中ZCCHC4的表达和功能作用.
- 确定ESCA患者中ZCCHC4表达和临床参数之间的关联.
- 阐明ZCCHC4对ESCA进展和西斯普拉丁耐药性的影响的潜在机制.
主要方法:
- 定量实时PCR (qRT-PCR) 和西布洛特用于ZCCHC4表达分析.
- 电化学发光免疫测试用于血清瘤标志物.
- 细胞增殖,细胞循环和细胞亡测定 (CCK8,流细胞计).
- 在小鼠模型中的体内研究.
主要成果:
- 在ESCA中,ZCCHC4表达与晚期癌症,淋巴结转移和较差的整体存活率有关.
- ZCCHC4 mRNA水平与血清瘤标志物 (CEA,SCC,TPA) 相相关.
- ZCCHC4 Knockdown增加了西斯的敏感性,诱导了DNA损伤,提高了活性氧物种 (ROS),触发了S相停止,增强了亡,并抑制了增殖.
- 过度表达ZCCHC4具有相反的效果,促进增殖和化学抵抗.
- 降低ZCCHC4的调节抑制了瘤的进展和在体内对西斯普拉丁的耐药性,可能通过ROS/c-myc轴.
结论:
- 降低ZCCHC4的调节使食道癌细胞对西斯普拉丁敏感,抑制增殖,并促进亡.
- ZCCHC4在ESCA的进展和化学抵抗中发挥着重要作用.
- ZCCHC4代表了一个潜在的辅助生物标志物用于诊断和治疗目标在食道癌症.
相关概念视频
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Epigenetic Regulation
30.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K

